We analyzed the use of the HLA*A2:01-positive multiple myeloma cell line U266 as a tool for the rapid assessment of HLA-A2-restricted WT1-specific T-cell responses following electroporation with full-length WT1 mRNA, in comparison with WT1 peptide loading. The gene discussed is WT1; the disease is plasma cell myeloma.